menu search

Moderna (mrna), merck's cancer jab delays melanoma recurrence

Detailed data from a mid-stage study shows that Moderna (MRNA)/Merck's personalized cancer vaccine cand...

April 17, 2023, 12:56 pm

Moderna shares fall despite promising data from cancer vaccine trial

Moderna's mRNA vaccine, when combined with Merck's blockbuster drug Keytruda, showed promise in treatin...

April 17, 2023, 11:30 am

Gritstone bio presents 6-month neutralizing antibody (nab) data at eccmid 2023 from two phase 1 studies evaluating self-amplifying mrna (samrna) against sars-cov-2 (coral)

— CORAL-CEPI: Primary series samRNA vaccination elicits strong neutralizing antibody (nAb) responses ...

April 17, 2023, 11:01 am

Moderna (mrna) stock sinks despite positive cancer vaccine update

Moderna (NASDAQ: MRNA ) stock is sinking this morning despite releasing positive data about its cancer vaccin<...

April 17, 2023, 10:00 am

This prediction may completely change your opinion of moderna

Investors have worried about declining coronavirus vaccine revenue at Moderna. The company has many pot...

April 17, 2023, 5:30 am

Wall street analysts are bullish on moderna stock price: should you?

Moderna (NASDAQ: MRNA) stock price will be in the spotlight on Monday after the company announced important outcome of its skin cancer v...

April 17, 2023, 3:55 am

: moderna, merck combo cancer-vaccine treatment shows ‘significant’ promise

A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising results in a key study...

April 16, 2023, 9:21 pm

Moderna, merck combo cancer-vaccine treatment shows ‘significant' promise

A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising results in a key study...

April 16, 2023, 5:21 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccin...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccin...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccin...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccin...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccin...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccin...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccin...

April 16, 2023, 5:00 pm


Search within

Pages Search Results: